Palvella Therapeutics (PVLA) FCF Margin Growth (5y) (2019 - 2024)
Palvella Therapeutics (PVLA) FCF Margin Growth (5y) (2019 - 2024) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Palvella Therapeutics |
1.49 Bn |
1.23 Bn |
- |
| Date | Value |
|---|
| Mar 31, 2024 |
-190,102.00 |
| Sep 30, 2023 |
11,280.00 |
| Jun 30, 2023 |
1,315.00 |
| Mar 31, 2023 |
-131,528.00 |
| Sep 30, 2022 |
-429,750.00 |
| Jun 30, 2022 |
-5,328.00 |
| Mar 31, 2022 |
-211,437.00 |
| Dec 31, 2021 |
1,598.00 |
| Sep 30, 2021 |
-3,052.00 |
| Jun 30, 2021 |
174,317.00 |
| Mar 31, 2021 |
-25,070.00 |
| Dec 31, 2020 |
-141,740.00 |
| Sep 30, 2020 |
67,112.00 |
| Jun 30, 2020 |
184,878.00 |
| Mar 31, 2020 |
154,112.00 |
| Sep 30, 2019 |
-1,081.00 |
| Jun 30, 2019 |
26,986.00 |
